查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575027

电脑模拟药物发现市场、副产品、疾病类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

In-Silico Drug Discovery Market, By Product, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，电脑模拟药物发现市场规模为 298,032 万美元，2024 年至 2032 年复合年增长率为 10.30%。

电脑模拟药物发现市场-市场动态

运算能力和人工智慧的进步以及结构生物学的出现，技术预计将推动市场需求

高效能运算 (HPC) 和基于云端的平台的可用性不断提高，使得更复杂的模拟和大规模资料处理成为可能。人工智慧（AI）和机器学习（ML）的整合进一步提高了药物发现的预测准确性和效率，从而促进了电脑模拟药物发现市场的成长。人工智慧和巨量资料分析被用来分析大型生物数据集，识别新的药物靶点，并预测药物交互作用和毒性特征，从而实现更精确和个性化的药物开发。

结构生物学、基因组学、蛋白质组学和代谢组学的进步产生了大量关于生物系统的资料。电脑药物发现工具利用这些资料来识别新的药物标靶并了解疾病机制。此外，製药公司和学术机构研发支出的增加，特别是在计算生物学和生物资讯学方面，导致更多地采用电脑工具进行药物发现和开发。许多製药公司将电脑药物发现流程外包给专业公司，促进市场成长。製药公司、学术机构和科技公司之间的合作也正在加速创新和市场扩张。

电脑模拟药物发现市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 10.30% 左右的复合年增长率成长

根据产品细分，由于网路普及率不断提高和物联网解决方案的采用，预计软体即服务细分市场将在 2023 年显示最大的市场份额。

根据疾病类型细分，由于肿瘤疾病的盛行率不断上升，肿瘤学细分市场将成为 2023 年领先的疾病类型细分市场。

根据最终用户细分，由于生物製药公司在药物发现方面的投资不断增加，生物製药公司细分市场将在 2023 年成为领先的最终用户细分市场。

从地区来看，由于顶级製药公司的存在和有利的政府政策，北美是 2023 年的主要收入来源。

电脑模拟药物发现市场 - 細項分析：

全球电脑模拟药物发现市场根据产品、疾病类型、最终用户和地区进行细分。

市场依产品分为两类：软体即服务及咨询即服务。软体即服务领域主导市场。巨量资料和人工智慧在医疗工具中的日益采用正在促进细分市场的成长。

依疾病类型，市场分为六类：肿瘤、神经系统疾病、感染性疾病、代谢性疾病、心血管疾病等。肿瘤学领域在市场上占据主导地位。癌症病例数量不断增加，据印度国立卫生研究院称，到2025年癌症病例预计将增加12.5%。

根据最终用户，市场分为四大类：生物製药公司、CRO、学术研究等。生物製药公司细分市场占据主导地位，预计在预测期内将保持其高度主导地位。生物製药公司简化药物开发并投资支持市场成长的研究。

电脑模拟药物发现市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美，尤其是美国，在电脑模拟药物发现市场中占有最大份额。在药物发现中采用人工智慧、机器学习和高效能运算 (HPC) 等先进技术。欧洲是第二大市场，德国、英国、法国等国家都有葛兰素史克、阿斯特捷利康等公司，这些公司都非常注重研发投入。

电脑模拟药物发现市场-竞争格局：

电脑模拟药物发现市场竞争激烈，公司越来越多地结合人工智慧和机器学习来提高预测准确性、降低成本并加快药物开发过程。 Insilico Medicine 和 Atomwise 等公司不断增强其人工智慧平台，以改善药物标靶识别、化合物优化和 ADMET（吸收、分布、代谢、排泄和毒性）特性的预测。此外，市场参与者正在向亚太地区等新兴市场扩张，这些市场对药物发现和生物资讯学的投资不断增加。

2023年，BenevolentAI与阿斯特捷利康达成策略合作，以发现和验证各个治疗领域的新标靶，包括慢性肾臟病和特发性肺纤维化。

2023年9月，资料科学驱动的药物发现公司Related Sciences与Charles River Laboratories International, Inc.合作，为许多未用药的目标部署了LogicaTM。

目录

第 1 章：电脑模拟药物发现市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 电脑模拟药物发现市场片段（按产品）
    • 按疾病类型分類的电脑模拟药物发现市场片段
    • 最终用户的电脑模拟药物发现市场片段
    • 按国家/地区分類的电脑模拟药物发现市场片段
    • 按地区分類的电脑模拟药物发现市场片段
  • 竞争洞察

第 3 章：电脑模拟药物发现主要市场趋势

  • 电脑模拟药物发现市场驱动因素
    • 市场驱动因素的影响分析
  • 电脑模拟药物发现市场限制
    • 市场限制影响分析
  • 电脑模拟药物发现市场机会
  • 电脑模拟药物发现市场未来趋势

第 4 章：电脑模拟药物发现产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：电脑模拟药物发现市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：电脑模拟药物发现市场格局

  • 2023 年电脑模拟药物发现市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：电脑模拟药物发现市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 软体即服务
    • 咨询即服务

第 8 章：电脑模拟药物发现市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 肿瘤学
    • 神经系统疾病
    • 传染性疾病
    • 代谢紊乱
    • 心血管疾病
    • 其他的

第 9 章：电脑模拟药物发现市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生物製药公司
    • 合约研究组织
    • 学术研究
    • 其他的

第 10 章：电脑模拟药物发现市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美电脑模拟药物发现主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲电脑模拟药物发现主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区电脑模拟药物发现主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲电脑模拟药物发现主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 电脑模拟药物发现中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：关键供应商分析 - 电脑模拟药物发现产业

  • 竞争仪表板
  • 公司简介
    • Schrodinger Inc.
    • Simulations Plus Inc.
    • Charles River Laboratories
    • Certara Inc.
    • Evotec SE
    • Insilico Medicine
    • Atomwise
    • BenevolentAI
    • Exscientia
    • Dassault Systemes (BIOVIA)
    • GNS Healthcare
    • Genedata AG
    • Collaborative Drug Discovery (CDD)
    • OpenEye Scientific Software
    • ChemAxon
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4020

REPORT HIGHLIGHT

In-Silico Drug Discovery Market size was valued at USD 2,980.32 Million in 2023, expanding at a CAGR of 10.30% from 2024 to 2032.

In-silico drug discovery utilizes computational methods and simulations to identify, design, and optimize potential drug candidates. This approach leverages computer-based tools to model biological systems, predict drug interactions, and explore chemical space, which significantly speeds up the drug discovery process and reduces costs compared to traditional experimental methods.

In-Silico Drug Discovery Market- Market Dynamics

Advancement in computational power & AI and emergence of structural biology, technologies is expected to propel market demand

The increased availability of high-performance computing (HPC) and cloud-based platforms has enabled more complex simulations and large-scale data processing. The integration of artificial intelligence (AI) and machine learning (ML) further enhances predictive accuracy and efficiency in drug discovery, thereby boosting the in-silico drug discovery market growth. AI and big data analytics are being used to analyze large biological datasets, identify new drug targets, and predict drug interactions and toxicity profiles, enabling more precise and personalized drug development.

Advances in structural biology, genomics, proteomics, and metabolomics have generated vast amounts of data on biological systems. In-silico drug discovery tools utilize this data to identify novel drug targets and understand disease mechanisms. In addition, increased R&D spending by pharmaceutical companies and academic institutions, especially in computational biology and bioinformatics, has led to greater adoption of in-silico tools for drug discovery and development. Many pharmaceutical companies are outsourcing in-silico drug discovery processes to specialized firms, leading to market growth. Collaborations between pharma companies, academic institutions, and tech firms are also accelerating innovation and market expansion.

In-Silico Drug Discovery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2024-2032)

Based on Product segmentation, the software-as-a-service segment was predicted to show maximum market share in the year 2023, owing to rising internet penetration & adoption of IoT solution.

Based on Disease Type segmentation, oncology segment was the leading Disease Type segment in 2023, due to the growing prevalence of oncological disorders.

Based on End User segmentation, biopharmaceutical companies' segment was the leading End User segment in 2023, due to the rising number investment by biopharma companies in drug discoveries.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of top pharma companies & favorable government policies.

In-Silico Drug Discovery Market- Segmentation Analysis:

Global In-Silico Drug Discovery Market is segmented on the basis of Product, Disease Type, End User, and Region.

The market is divided into two categories based on Product: software-as-a-service and consultancy-as-a-service. The software-as-a-service segment dominates the market. The increasing adoption of big data and AI in medical tools is contributing to segment growth.

The market is divided into six categories based on Disease Type: oncology, neurological disorders, infectious disorders, metabolic disorders, cardiovascular diseases, and others. The oncology segment dominates the market. The increasing number of cancer cases, according to NIH, India, cancer cases are expected to rise by 12.5% by 2025.

The market is divided into four categories based on End User: biopharmaceutical companies, CROs, academic research, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Biopharmaceutical companies streamline their drug development & investing in research supporting market growth.

In-Silico Drug Discovery Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, especially the United States, holds the largest share in the in-silico drug discovery market. Adoption of advanced technologies like AI, machine learning, and high-performance computing (HPC) in drug discovery. Europe is the second-largest market, with countries like Germany, the UK, and France with companies like GSK, AstraZeneca, etc. These companies are emphasizing on high investment in research and development (R&D).

In-Silico Drug Discovery Market- Competitive Landscape:

The In-Silico Drug Discovery market is highly competitive, Companies are increasingly incorporating AI and machine learning to enhance prediction accuracy, reduce costs, and speed up the drug development process. Companies such as Insilico Medicine and Atomwise are continually enhancing their AI platforms to improve drug target identification, compound optimization, and prediction of ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties. Also, market players are expanding into emerging markets like Asia-Pacific, where investments in drug discovery and bioinformatics are increasing.

In 2023, BenevolentAI entered a strategic collaboration with AstraZeneca to discover and validate novel targets across various therapeutic areas, including chronic kidney disease and idiopathic pulmonary fibrosis.

In September 2023, Related Sciences, a data science-driven drug discovery company collaborated with Charles River Laboratories International, Inc. to deploy LogicaTM for numerously undrugged targets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-SILICO DRUG DISCOVERY MARKET KEY PLAYERS

  • Schrodinger Inc.
  • Simulations Plus Inc.
  • Charles River Laboratories
  • Certara Inc.
  • Evotec SE
  • Insilico Medicine
  • Atomwise
  • BenevolentAI
  • Exscientia
  • Dassault Systemes (BIOVIA)
  • GNS Healthcare
  • Genedata AG
  • Collaborative Drug Discovery (CDD)
  • OpenEye Scientific Software
  • ChemAxon
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Software-as-a-service
  • Consultancy-as-a-service

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Oncology
  • Neurological disorders
  • Infectious disorders
  • Metabolic disorders
  • Cardiovascular diseases
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical companies
  • CROs
  • Academic research
  • Others

GLOBAL IN-SILICO DRUG DISCOVERY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-Silico Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-Silico Drug Discovery Market Snippet by Product
    • 2.1.2. In-Silico Drug Discovery Market Snippet by Disease Type
    • 2.1.3. In-Silico Drug Discovery Market Snippet by End User
    • 2.1.4. In-Silico Drug Discovery Market Snippet by Country
    • 2.1.5. In-Silico Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. In-Silico Drug Discovery Key Market Trends

  • 3.1. In-Silico Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-Silico Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-Silico Drug Discovery Market Opportunities
  • 3.4. In-Silico Drug Discovery Market Future Trends

4. In-Silico Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-Silico Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-Silico Drug Discovery Market Landscape

  • 6.1. In-Silico Drug Discovery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-Silico Drug Discovery Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Software-as-a-service
    • 7.1.3. Consultancy-as-a-service

8. In-Silico Drug Discovery Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurological disorders
    • 8.1.4. Infectious disorders
    • 8.1.5. Metabolic disorders
    • 8.1.6. Cardiovascular diseases
    • 8.1.7. Others

9. In-Silico Drug Discovery Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical companies
    • 9.1.3. CROs
    • 9.1.4. Academic research
    • 9.1.5. Others

10. In-Silico Drug Discovery Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-Silico Drug Discovery Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-Silico Drug Discovery Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-Silico Drug Discovery Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-Silico Drug Discovery Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-Silico Drug Discovery Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-Silico Drug Discovery Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Schrodinger Inc.
    • 11.2.2. Simulations Plus Inc.
    • 11.2.3. Charles River Laboratories
    • 11.2.4. Certara Inc.
    • 11.2.5. Evotec SE
    • 11.2.6. Insilico Medicine
    • 11.2.7. Atomwise
    • 11.2.8. BenevolentAI
    • 11.2.9. Exscientia
    • 11.2.10. Dassault Systemes (BIOVIA)
    • 11.2.11. GNS Healthcare
    • 11.2.12. Genedata AG
    • 11.2.13. Collaborative Drug Discovery (CDD)
    • 11.2.14. OpenEye Scientific Software
    • 11.2.15. ChemAxon
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us